Product Information
TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Baxter Healthcare Corporation, priced at $0.6528 per ML under NDC 36000024425. Its NADAC has been published 167 times since Aug 18, 2021.
The Low Outlier badge above means this manufacturer's average price in the Tobramycin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Baxter Healthcare CorporationNDC
36000024425
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
TOBRAMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA206965On Market Since
7/15/2016
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 167 times since Aug 18, 2021, and over the history we have for it it has declined 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6528 per ML |
|---|---|
| All-time high | $0.9396 (Jun 12, 2024) |
| All-time low | $0.5997 (Mar 18, 2026) |
| 52-week high | $0.8372 |
| 52-week low | $0.5997 |
| Median price | $0.8372 |
| Average price | $0.8075 |
| Largest weekly change | -16.2% (Nov 20, 2024) |
| Weeks tracked | 167 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Baxter Healthcare Corporation, is $0.6528 per ML (NDC 36000024425), effective Jun 24, 2026.
How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 23.2%. It has been tracked across 167 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?
Since Aug 18, 2021, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $0.9396 (Jun 12, 2024), with a median of $0.8372 per ML.
Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TOBRAMYCIN 80 MG/2 ML VIAL, but none are currently priced below it.
Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?
TOBRAMYCIN 80 MG/2 ML VIAL (NDC 36000024425) is labeled by Baxter Healthcare Corporation, and CMS classifies it as a generic product.
Related Drugs
Same classification